Hold Dr Reddys Labs; target of Rs 1700: Emkay - MoneyControl.com

US business grew 48% to USD175mn led by launch of Geodon & Seroquel generics Going forward " There are 10-15 products including para-IV’s lined-up for launch in FY13 in US which are critical for the company to achieve USD2.7bn revenue target ...

Generic Plavix® to Arrive at All Walmart and Sam's Club Pharmacies on May 19 - Marketwatch

Generic Substitute For Available Escitalopram Lexapro® Available Now Ibandronate Boniva® Available Now Irbesartan Avapro® Available Now Modafinil Provigil® Available Now Quetiapine Seroquel® Available Now Ziprasidone HPI Geodon® Available ...

Dr. Reddy's Labs 4Q profit rises 2 percent - Yahoo Finance

The company said its North American revenue rose 36 percent to 8.7 billion rupees ($167 million) as it began selling generic versions of the schizophrenia treatment Geodon and antibiotic Amoxil, and sales of generic versions of the heartburn ...

India Dr Reddy's N. America sales offset charge in Q4 - Reuters

Sales in North America, a major market for generic Indian drugs, j umped 36 percent to 8.7 billion rupees, h elped by the launch of its copycat versions of Pfizer's schizophrenia drug Geodon and Glaxo Group's Arixtra that prevents blood clots.

Lupin Fourth-Quarter Net Profit Falls 31%, Misses View - FOXBusiness

Analysts expected better operating margin in the fourth quarter, driven by U.S. sales of a generic version of Pfizer Inc.'s Geodon capsules for treating schizophrenia. Lupin, being one of the first generic applicants for Geodon, enjoys shared ...

Generic Lipitor Hurts Pfizer - Analyst Blog - NASDAQ

A change in the method of reporting Vfend, Geodon and Xalatan revenues also affected revenues - from January 1, Pfizer started including Vfend, Geodon and Xalatan revenues as a part of the Established Products unit. The change in reporting for ...

Lupin report: New launches continue to fuel US growth - Stock Markets Review

With the recent launches of Geodon (March 2012) and Combivir, resumption of Fortamet sales (April 2012) and slated launch of Tricor (possibly in July 2012), we believe US generics will continue to dominate the growth theme and thereby drive earnings growth.

Schizophrenia and Medication - Part Two - HealthCentral.com

In April 2007, my current doctor switched me to Geodon which I've been on over five years now. A curious fate for those of us who won the war against the symptoms and got our lives back better than before is that certain providers don't believe we could ...

US, Russia & API boost Dr Reddy's as busy year looms - MoneyControl.com

Just give us a sense on how exactly did Olanzapine perform with your share being below USD 2 million. Is that a concern and how did Geodon Generic contribute? A: Coming to the performance on Olanzapine, it is slightly less than what we internally thought.